Great Elm Capital Corp. (GECC)

Blueprint Medicines Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Other Revenue	47.64	39.32	35.83	24.43	25.25	22.9
Revenue	47.64	39.32	35.83	24.43	25.25	22.9
Revenue Growth (YoY)	29.12%	9.76%	46.65%	-3.27%	10.29%	-15.32%
Gross Profit	47.64	39.32	35.83	24.43	25.25	22.9
Selling, General & Admin	13.31	11.64	11.25	3.03	2.49	6.61
Operating Expenses	13.31	11.64	11.25	3.03	2.49	6.61
Operating Income	34.33	27.68	24.57	21.4	22.76	16.29
Interest Expense	-17.17	-14.88	-11.74	-10.69	-10.43	-9.13
EBT Excluding Unusual Items	17.16	12.8	12.83	10.71	12.33	7.17
Gain (Loss) on Sale of Investments	0.85	-8.9	12.79	-26.04	-22.56	-40.34
Other Unusual Items	-0	-0	-	-	-	1.24
Pretax Income	18.01	3.9	25.62	-15.33	-10.23	-31.94
Income Tax Expense	0.48	0.35	0.29	0.25	0.05	0.02
Net Income	17.53	3.55	25.33	-15.58	-10.28	-31.96
Net Income to Common	17.53	3.55	25.33	-15.58	-10.28	-31.96
Net Income Growth	72.11%	-85.97%	-	-	-	-
Shares Outstanding (Basic)	11	10	8	6	4	2
Shares Outstanding (Diluted)	11	10	8	6	4	2
Shares Change (YoY)	32.48%	29.49%	21.60%	53.47%	83.63%	29.85%
EPS (Basic)	1.58	0.36	3.33	-2.49	-2.52	-14.41
EPS (Diluted)	1.58	0.36	3.33	-2.49	-2.52	-14.41
EPS Growth	29.92%	-89.17%	-	-	-	-
Dividend Per Share	0.700	1.400	1.400	1.950	2.400	6.000
Dividend Growth	-50.00%	-	-28.21%	-18.75%	-60.00%	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	72.07%	70.40%	68.59%	87.61%	90.13%	71.15%
Profit Margin	36.80%	9.04%	70.71%	-63.79%	-40.69%	-139.56%
EBIT	34.33	27.68	24.57	21.4	22.76	16.29
EBIT Margin	72.07%	70.40%	68.59%	87.61%	90.13%	71.15%
Effective Tax Rate	2.66%	8.92%	1.12%	-	-	-
Revenue as Reported	47.64	39.32	35.83	24.43	25.25	22.9

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q